Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon alpha with or without thalidomide for metastatic renal cell carcinoma
ISRCTN11978947Phase 2Terminated
- Sponsor
- UK Co-ordinating Committee for Cancer Research
- Start
- Feb 2001
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Phase 2, randomised, open-label trial in renal cell carcinoma (RCC) comparing Interferon alpha with Interferon alpha + thalidomide (2 arms). Started Feb 2001; status: terminated.
02
Drugs
interferon alfathalidomide
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on ISRCTN11978947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11978947.